• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝病患者的抗凝血酶III代谢

Antithrombin III metabolism in patients with liver disease.

作者信息

Knot E, Ten Cate J W, Drijfhout H R, Kahlé L H, Tytgat G N

出版信息

J Clin Pathol. 1984 May;37(5):523-30. doi: 10.1136/jcp.37.5.523.

DOI:10.1136/jcp.37.5.523
PMID:6725600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC498774/
Abstract

Liver diseases are associated with complex haemostasis defects, in which platelets, coagulation, and fibrinolysis may all be affected. The low plasma concentrations of clotting factors often found can be the result of many changes such as impaired synthesis, increased catabolism due to intravascular coagulation, or alternate distribution. In this study, we investigated the metabolism of purified human antithrombin III(AT III) labelled with 125I in 25 patients with histologically established liver disease and in nine control subjects. The results showed that, in general, low plasma concentrations of AT III in liver cirrhosis are not due to consumption in the central compartment but rather to altered transcapillary flux ratio. Such altered transcapillary flux ratios may already exist even with normal plasma AT III concentrations. Altered ratios are not only found for coagulation proteins but also for albumin and thus may be a general phenomenon of liver disease. In micronodular cirrhosis the alpha phase, the transcapillary efflux (k1, 2) and influx (k2, 1) were significantly increased compared with the normal subjects.

摘要

肝脏疾病与复杂的止血缺陷有关,其中血小板、凝血和纤溶都可能受到影响。经常发现的凝血因子血浆浓度低可能是多种变化的结果,如合成受损、血管内凝血导致的分解代谢增加或分布改变。在本研究中,我们调查了25例经组织学确诊的肝病患者和9名对照受试者中用125I标记的纯化人抗凝血酶III(AT III)的代谢情况。结果表明,一般来说,肝硬化患者血浆AT III浓度低并非由于中央室的消耗,而是由于跨毛细血管通量率改变。即使血浆AT III浓度正常,这种改变的跨毛细血管通量率也可能已经存在。不仅凝血蛋白存在改变的比率,白蛋白也是如此,因此这可能是肝病的普遍现象。在小结节性肝硬化的α期,与正常受试者相比,跨毛细血管流出(k1,2)和流入(k2,1)显著增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66ca/498774/ca9a33fef950/jclinpath00176-0044-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66ca/498774/ca9a33fef950/jclinpath00176-0044-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66ca/498774/ca9a33fef950/jclinpath00176-0044-a.jpg

相似文献

1
Antithrombin III metabolism in patients with liver disease.肝病患者的抗凝血酶III代谢
J Clin Pathol. 1984 May;37(5):523-30. doi: 10.1136/jcp.37.5.523.
2
alpha 2-Plasmin inhibitor metabolism in patients with liver cirrhosis.
J Lab Clin Med. 1985 Mar;105(3):353-8.
3
Antithrombin III transfusion in patients with hepatic cirrhosis.肝硬化患者的抗凝血酶III输注
Br J Haematol. 1982 Sep;52(1):25-33. doi: 10.1111/j.1365-2141.1982.tb03858.x.
4
Metabolism of antithrombin III in cirrhosis and carcinoma of the liver.肝硬化和肝癌中抗凝血酶III的代谢
Clin Sci (Lond). 1981 Jun;60(6):681-8. doi: 10.1042/cs0600681.
5
Deficient antithrombin III activity and enhanced fibrinolysis in patients with liver disease: evidence against a cause-effect relationship.
Acta Gastroenterol Belg. 1995 Mar-Apr;58(2):230-7.
6
Plasma antithrombin III, alpha 2-plasmin inhibitor and plasminogen activities in cases of various liver diseases.各种肝病患者血浆抗凝血酶III、α2-纤溶酶抑制剂及纤溶酶原活性
Tokai J Exp Clin Med. 1986 Nov;11(5):345-52.
7
Purified radiolabeled antithrombin III metabolism in three families with hereditary AT III deficiency: application of a three-compartment model.三个遗传性抗凝血酶III缺乏症家族中纯化放射性标记抗凝血酶III的代谢:三室模型的应用
Blood. 1986 Jan;67(1):93-8.
8
Coagulation and fibrinolysis in orthotopic liver transplantation: role of the recipient's disease and use of antithrombin III concentrates. S. Orsola Working Group on Liver Transplantation.原位肝移植中的凝血与纤溶:受者疾病的作用及抗凝血酶III浓缩物的应用。索尔拉医院肝移植工作组
Haemostasis. 1991;21(2):68-76. doi: 10.1159/000216206.
9
Circadian rhythms of fibrinogen and antithrombin III in liver cirrhosis.肝硬化患者纤维蛋白原和抗凝血酶III的昼夜节律
Riv Eur Sci Med Farmacol. 1995 Jul-Aug;17(4):125-9.
10
Metabolism of fibrinogen in cirrhosis of the liver.肝脏肝硬化中纤维蛋白原的代谢
J Clin Invest. 1971 Aug;50(8):1690-701. doi: 10.1172/JCI106658.

引用本文的文献

1
Prognostic Value of Antithrombin Activity Levels in the Early Phase of Intensive Care: A 2-Center Retrospective Cohort Study.重症监护早期抗凝血酶活性水平的预后价值:一项 2 中心回顾性队列研究。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231218711. doi: 10.1177/10760296231218711.
2
Plasma Antithrombin III Levels Can Be a Prognostic Factor in Liver Cirrhosis Patients with Portal Vein Thrombosis.血浆抗凝血酶 III 水平可作为门静脉血栓形成的肝硬化患者的预后因素。
Int J Mol Sci. 2023 Apr 23;24(9):7732. doi: 10.3390/ijms24097732.
3
Low Preoperative Antithrombin III Level Is Associated with Postoperative Acute Kidney Injury after Liver Transplantation.

本文引用的文献

1
INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.遗传性抗凝血酶缺乏导致血栓形成倾向。
Thromb Diath Haemorrh. 1965 Jun 15;13:516-30.
2
ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.抗原-抗体交叉电泳
Anal Biochem. 1965 Feb;10:358-61. doi: 10.1016/0003-2697(65)90278-2.
3
COAGULATION STUDIES IN LIVER DISEASE.肝病中的凝血研究
术前抗凝血酶III水平低与肝移植术后急性肾损伤相关。
J Pers Med. 2021 Jul 26;11(8):716. doi: 10.3390/jpm11080716.
4
Clinical Significance of Serum Antithrombin III Activity After Hepatectomy for Hepatocellular Carcinoma.肝细胞癌肝切除术后血清抗凝血酶III活性的临床意义
Yonago Acta Med. 2021 Apr 15;64(2):168-175. doi: 10.33160/yam.2021.05.007. eCollection 2021 May.
5
Physiological changes of pregnancy and the Swansea criteria in diagnosing acute fatty liver of pregnancy.妊娠的生理变化及斯旺西标准在诊断妊娠急性脂肪肝中的应用
Obstet Med. 2018 Sep;11(3):126-131. doi: 10.1177/1753495X18759353. Epub 2018 Apr 16.
6
The influence of antithrombin III (AT III) substitution to supranormal activities on systemic procoagulant turnover in patients with end-stage chronic liver disease.抗凝血酶III(AT III)替代至超正常活性对终末期慢性肝病患者全身凝血因子周转的影响。
Intensive Care Med. 1997 Nov;23(11):1150-8. doi: 10.1007/s001340050472.
7
Hepatocarcinoma in cirrhosis. Is antithrombin III a neoplastic marker?肝硬化中的肝癌。抗凝血酶III是一种肿瘤标志物吗?
Dig Dis Sci. 1991 Jul;36(7):990-2. doi: 10.1007/BF01297153.
Thromb Diath Haemorrh. 1964 Apr 15;11:51-63.
4
[A SCREENING-TEST, FOLLOWED BY A RAPID QUANTITATIVE MICRODETERMINATION OF PLASMA FIBRINOGEN].[一项筛查试验,随后进行血浆纤维蛋白原的快速定量微量测定]
Ned Tijdschr Geneeskd. 1963 Nov 2;107:2044-5.
5
SERUM ALBUMIN TURNOVER IN NORMAL SUBJECTS AND PATIENTS WITH CIRRHOSIS MEASURED BY 131I-LABELLED HUMAN ALBUMIN.用¹³¹I标记的人白蛋白测定正常人和肝硬化患者的血清白蛋白周转率。
Clin Sci. 1963 Oct;25:281-92.
6
The kaolin clotting time; a rapid one-stage method for diagnosis of coagulation defects.高岭土凝血时间;一种用于诊断凝血缺陷的快速一步法。
J Clin Pathol. 1958 Sep;11(5):406-9. doi: 10.1136/jcp.11.5.406.
7
The theory of tracer experiments with 131I-labelled plasma proteins.用131I标记血浆蛋白的示踪实验理论
Phys Med Biol. 1957 Jul;2(1):36-53. doi: 10.1088/0031-9155/2/1/305.
8
Exchange between intravascularly and extravascularly injected radioiodinated fibrinogen and its in vivo derivatives.
J Lab Clin Med. 1980 Jun;95(6):842-56.
9
Mechanized amidolytic technique for determination of factor X and factor-X antigen, and its application to patients being treated with oral anticoagulants.用于测定因子X和因子X抗原的机械化酰胺水解技术及其在口服抗凝剂治疗患者中的应用。
Clin Chem. 1980 Jun;26(7):885-90.
10
Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen).使用固相氧化剂1,3,4,6-四氯-3α,6α-二苯基甘脲(碘苷)对蛋白质、糖蛋白和肽进行碘化。
Anal Biochem. 1981 Oct;117(1):136-46. doi: 10.1016/0003-2697(81)90703-x.